Antibody Levels against -Galactosyl Epitopes in Sera of Patients with Squamous Intraepithelial Lesions and Early Invasive Cervical Carcinoma

By Tremont-Lukats I.W.   Avila J.L.   Hernandez D.   Vasquez J.   Teixeira G.M.   Rojas M.  

Gynecologic Oncology, Vol. 64, Iss. 2, 1997-02 ,pp. : 207-212

Elsevier

Access to resources Recommend Favorite

Effects of -Carotene and Other Factors on Outcome of Cervical Dysplasia and Human Papillomavirus Infection

By Romney S.L.   Ho G.Y.F.   Palan P.R.   Basu J.   Kadish A.S.   Klein S.   Mikhail M.   Hagan R.J.   Chang C.J.   Burk R.D.  

Gynecologic Oncology, Vol. 65, Iss. 3, 1997-06 ,pp. : 483-492

Elsevier

Access to resources Recommend Favorite

Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma

By              

International Journal of Oncology, Vol. 42, Iss. 1, 2013-01 ,pp. : 247-252

Spandidos Publications

Access to resources Recommend Favorite

Vaccination against human papillomavirus types 16 and 18: the impact on cervical cancer

By Berkhof Johannes   Bogaards Johannes A  

Future Oncology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1817-1821

Future Medicine

Access to resources Recommend Favorite

Telomerase activity and human papillomavirus (HPV) infection in human uterine cervical cancers and cervical smears

By Kawai K.   Yaginuma Y.   Tsuruoka H.   Griffin M.   Hayashi H.   Ishikawa M.  

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2082-2086

Elsevier

Access to resources Recommend Favorite